TherapeuticsMD, Inc.

NasdaqGS TXMD

TherapeuticsMD, Inc. Price to Sales Ratio (P/S) on January 14, 2025: 7.20

TherapeuticsMD, Inc. Price to Sales Ratio (P/S) is 7.20 on January 14, 2025, a NA change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

TherapeuticsMD, Inc. 52-week high Price to Sales Ratio (P/S) is 11.99 on October 07, 2024, which is 66.48% above the current Price to Sales Ratio (P/S).
TherapeuticsMD, Inc. 52-week low Price to Sales Ratio (P/S) is 6.24 on December 31, 2024, which is -13.40% below the current Price to Sales Ratio (P/S).
TherapeuticsMD, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 10.05.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqGS: TXMD

TherapeuticsMD, Inc.

CEO	Mr. Marlan D. Walker J.D.
IPO Date	May 9, 2007
Location	United States
Headquarters	951 Yamato Road
Employees	1
Sector	Health Care
Industries Pharmaceuticals

Description

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Key trends

Past 5 years